Literature DB >> 6135030

N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia.

J J Lipsky.   

Abstract

Several new antibiotics which contain an N-methyl-thio-tetrazole side chain have been associated with the development of hypoprothrombinaemia. This side chain was found to be capable of the in-vitro inhibition of a necessary reaction in the synthesis of prothrombin, the gamma carboxylation of glutamic acid. The 50% inhibitory concentration was 1.1 mmol/l. The intact antibiotics latamoxef, cephamandole, and cefoperazone, which contain the side chain, did not inhibit the reaction at concentrations up to 2 mmol/l. These results suggest that hypoprothrombinaemia associated with antibiotics containing N-methyl-thio-tetrazole side chains may be a consequence of the in-vivo degradation of these antibiotics and the subsequent inhibition of the gamma carboxylation of glutamic acid by the side chain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135030     DOI: 10.1016/s0140-6736(83)90174-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Increased PIVKA-II concentrations in patients with cystic fibrosis.

Authors:  M de Montalembert; G Lenoir; A Saint-Raymond; J Rey; J J Lefrère
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

2.  Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations.

Authors:  I J Mackie; K Walshe; H Cohen; P McCarthy; M Shearer; S D Scott; S J Karran; S J Machin
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

3.  Comparative effects of cefoxitin and cefotetan on vitamin K metabolism.

Authors:  R R Sieradzan; W A Bottner; M J Fasco; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Effects of aztreonam on fecal flora and on vitamin K metabolism.

Authors:  H Sakata; H Kakehashi; K Fujita; H Yoshioka
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Hypoprothrombinemia due to cefamandole.

Authors:  V M Conraads; H E Demey; L G Heytens; L L Bossaert
Journal:  Klin Wochenschr       Date:  1988-12-01

6.  A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.

Authors:  G B Calandra; M Hesney; C Grad
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

7.  Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.

Authors:  R L Nichols; M A Wikler; J T McDevitt; A L Lentnek; J A Hosutt
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 8.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

9.  The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin.

Authors:  D M Angaran; V C Dias; K V Arom; W F Northrup; T G Kersten; W G Lindsay; D M Nicoloff
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

10.  Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics.

Authors:  J J Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.